LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-26
DOI
10.1186/s13046-021-01854-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma
- (2020) Xia Liao et al. BMC CANCER
- PLAGL2‐EGFR‐HIF‐1/2α signaling loop promotes HCC progression and Erlotinib insensitivity
- (2020) Weiwei Hu et al. HEPATOLOGY
- Role of the mTOR pathway in liver cancer: from molecular genetics to targeted therapies
- (2020) Xinjun Lu et al. HEPATOLOGY
- MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
- (2020) Honglei Wu et al. Cell Death & Disease
- The Underlying Mechanisms of Non-Coding RNAs in the Chemoresistance of Hepatocellular Carcinoma
- (2020) Man Wang et al. Molecular Therapy-Nucleic Acids
- Glycochenodeoxycholic acid induces stemness and chemoresistance via the STAT3 signaling pathway in hepatocellular carcinoma cells
- (2020) Changying Shi et al. Aging-US
- The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression
- (2020) Chao Tu et al. CELL PROLIFERATION
- HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis
- (2020) Yifan Zhang et al. EXPERIMENTAL CELL RESEARCH
- Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression
- (2020) Qing Han et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
- (2020) Yi Luo et al. Frontiers in Pharmacology
- A novel pseudogene-derived lncRNA, RP11-480I12.5-004, promotes growth and tumorigenesis of breast cancer through relieving miR-29c-3p-mediated AKT3 and CDK6 degradation
- (2020) Weiyang Lou et al. Molecular Therapy-Nucleic Acids
- SP1‐induced lncRNA FOXD3‐AS1 contributes to tumorigenesis of cervical cancer by modulating the miR‐296‐5p/HMGA1 pathway
- (2020) Wen‐guang Ma et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- lncRNA‐POIR promotes epithelial–mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR‐182‐5p
- (2020) Bryan Wei Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Circ_0000144 facilitates the progression of thyroid cancer via the miR‐217/AKT3 pathway
- (2020) Yi‐Xiang Fan et al. JOURNAL OF GENE MEDICINE
- PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma
- (2020) Yuting Wu et al. PHARMACOLOGICAL RESEARCH
- lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription
- (2020) Xue Gong et al. Molecular Therapy-Nucleic Acids
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
- (2019) Yi Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
- (2019) Xia Liao et al. Hepatology International
- ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer
- (2019) Hengqiang Zhao et al. Molecular Therapy-Oncolytics
- RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC)
- (2019) Min-Li Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- LINC00680 and TTN-AS1 Stabilized by EIF4A3 Promoted Malignant Biological Behaviors of Glioblastoma Cells
- (2019) Wei Tang et al. Molecular Therapy-Nucleic Acids
- Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling
- (2018) Jianting Long et al. CANCER LETTERS
- lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141
- (2018) Lili Wu et al. Cell Communication and Signaling
- Epidermal growth factor receptor transactivation is involved in the induction of human hepatoma SMMC7721 cell proliferation by insufficient radiofrequency ablation
- (2017) Hongliang Dai et al. Oncology Letters
- Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells
- (2015) B. W. Chen et al. MOLECULAR CANCER THERAPEUTICS
- 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice
- (2014) Chunmei Wang et al. HEPATOLOGY
- Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway
- (2014) Yanqiong Zhang et al. Molecular Cancer
- The evolution of lncRNA repertoires and expression patterns in tetrapods
- (2014) Anamaria Necsulea et al. NATURE
- miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
- (2013) Rounak Nassirpour et al. PLoS One
- Long non-coding RNAs: insights into functions
- (2009) Tim R. Mercer et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started